CARDIOPULMONARY BYPASS DOES NOT ALTER CANINE ENFLURANE REQUIREMENTS

被引:11
|
作者
ANTOGNINI, JF
KIEN, ND
机构
[1] Department of Anesthesiology, University of California, Davis
关键词
ANESTHETICS; VOLATILE; ENFLURANE; POTENCY; ANESTHETIC; MAC; SURGERY; CARDIOVASCULAR; CARDIOPULMONARY BYPASS;
D O I
10.1097/00000542-199206000-00014
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This study determined the effect of cardiopulmonary bypass (CPB) on canine enflurane minimum alveolar concentration (MAC). Fourteen dogs were anesthetized with enflurane in N2O and O2, and after tracheal intubation, the N2O was discontinued. Femoral arterial and pulmonary arterial catheters were placed, and MAC was determined with the tail-clamp method. CPB was initiated via the femoral artery-vein route, with additional venous return obtained from an external jugular vein. Partial CPB was used in the first 10 dogs. In 4 dogs, a membrane oxygenator (group 1) was used, and in the next 6 dogs a bubble oxygenator (group 2) was used. In 4 additional dogs (group 3), using bubble oxygenators, total CPB was achieved by occlusion of the pulmonary artery via a left thoracotomy. The CPB circuit was primed with Ringer's lactate, and circuit blood flows were 70-125 ml.kg-1.min-1, with mean arterial pressures maintained at 50-110 mmHg. MAC was determined again after termination of CPB. In 10 dogs, MAC was also measured during CPB. In 5 dogs MAC was measured after administration of protamine. MAC in all 14 dogs did not change (2.2 +/- 0.3 vs. 2.3 +/- 0.3). MAC remained constant in group 1 (2.4 +/- 0.3 vs. 2.3 +/- 0.4), group 2 (2.2 +/- 0.2 vs. 2.3 +/- 0.3), and group 3 (2.2 +/- 0.1 vs. 2.3 +/- 0. 1). Similarly, MAC was unchanged during CPB (2.2 +/- 0.2 vs. 2.2 +/- 0.2) and after protamine (2.3 +/- 0.2 vs. 2.2 +/- 0.3). Temperature was 38.3 +/- 1.2 prebypass and 37.9 +/- 0.9 postbypass. Hematocrit decreased from 38% to 28% post-CPB (P < 0.05), and pulmonary artery pressure increased slightly (P < 0.05). We conclude that CPB does not alter canine enflurane MAC.
引用
收藏
页码:953 / 957
页数:5
相关论文
共 50 条
  • [21] Does gastric bypass alter alcohol metabolism?
    Hagedorn, Judith C.
    Encarnacion, Betsy
    Brat, Gabriel A.
    Morton, John M.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2007, 3 (05) : 543 - 548
  • [22] Does cardiopulmonary bypass affect the procalcitonin level?
    F Kalay
    Y Bicer
    S Simsek
    N Yapici
    Z Alicikus
    G Golcuklu
    Z Aykac
    Critical Care, 9 (Suppl 1):
  • [23] Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass
    Feng, Junbo
    Liu, Haiyuan
    Chen, Jiayi
    Wang, Jiyuan
    Liu, Zhuang
    Ge, Shenglin
    KOREAN CIRCULATION JOURNAL, 2016, 46 (03) : 402 - 407
  • [24] Interleukin 6 induction in the canine myocardium after cardiopulmonary bypass
    Dreyer, WJ
    Phillips, SC
    Lindsey, ML
    Jackson, P
    Bowles, NE
    Michael, LH
    Entman, ML
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 120 (02): : 256 - 263
  • [25] EFFICACY OF APROTININ WITH VARIOUS ANTICOAGULANTS IN A CANINE MODEL OF CARDIOPULMONARY BYPASS
    TERRELL, MR
    KOZA, MJ
    WALENGA, JM
    KHENKINA, Y
    PIFARRE, R
    BLOOD, 1994, 84 (10) : A470 - A470
  • [26] ENERGY-METABOLISM OF CANINE HEART DURING CARDIOPULMONARY BYPASS
    JALONEN, J
    HALKOLA, L
    HAVIA, T
    NIINIKOSKI, J
    UPSALA JOURNAL OF MEDICAL SCIENCES, 1977, : 90 - 90
  • [27] Circuits with surface modifying additive alter the haemodynamic response to cardiopulmonary bypass
    Rubens, FD
    Ruel, M
    Lavallee, G
    Watson, M
    Robblee, J
    Wozny, D
    Nathan, H
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 15 (03) : 353 - 358
  • [28] Myocardial protection by ischemic preconditioning and enflurane anesthesia during coronary surgery without cardiopulmonary bypass
    Drenger, B
    Elami, A
    Gilon, D
    Maroz, Y
    Milgalter, E
    Chevion, M
    Gozal, Y
    ANESTHESIA AND ANALGESIA, 1999, 88 (04): : U123 - U123
  • [29] Specific requirements for bloodless cardiopulmonary bypass in neonates and infants; a review
    Golab, Hanna D.
    Takkenberg, Johanna J. M.
    Bogers, Ad J. J. C.
    PERFUSION-UK, 2010, 25 (04): : 237 - 243
  • [30] REHEPARINISATION REQUIREMENTS AFTER CARDIOPULMONARY BYPASS IN PATIENTS TREATED WITH APROTININ
    BAILEY, CR
    FISHER, AR
    WIELOGORSKI, AK
    BRITISH HEART JOURNAL, 1994, 72 (05): : 442 - 445